Cite
HARVARD Citation
Smith, J. et al. (2023). Tumor immune microenvironment alterations using induction cetuximab in a phase II trial of deintensified therapy for p16‐positive oropharynx cancer. Head & neck. 45 (5), pp. 1281-1287. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Smith, J. et al. (2023). Tumor immune microenvironment alterations using induction cetuximab in a phase II trial of deintensified therapy for p16‐positive oropharynx cancer. Head & neck. 45 (5), pp. 1281-1287. [Online].